Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
TNXP
TNXP
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
TNXP News
TNXP Shares Plummet for Four Consecutive Days as Investors Anticipate Drug Pipeline Returns
2d ago
stocktwits
Life Sciences Virtual Investor Forum Highlights Available On-Demand
Mar 13 2026
Globenewswire
Tonix Pharmaceuticals Reports Strong Q4 Results with Nearly Doubling Sales
Mar 13 2026
Benzinga
Tonix Pharmaceuticals Reports Q4 Loss Amid Early Drug Adoption
Mar 13 2026
stocktwits
Tonix Pharmaceuticals Q4 Earnings Beat Expectations with Revenue Surge
Mar 12 2026
seekingalpha
Tonix Pharmaceuticals Reports Q4 Net Loss of $46.91 Million
Mar 12 2026
moomoo
Life Sciences Virtual Investor Forum Agenda Announced
Mar 10 2026
Globenewswire
TONMYA Launches as New Treatment for Fibromyalgia
Mar 09 2026
Newsfilter
TONMYA Receives FDA Approval for Fibromyalgia Treatment
Mar 05 2026
Newsfilter
Tonix Pharmaceuticals to Present Tonmya at AAPM Annual Meeting
Mar 03 2026
Newsfilter
Tonix Pharmaceuticals Shares Decline Post Nasdaq Uplisting
Mar 03 2026
Benzinga
Tonix Pharmaceuticals Successfully Uplists to Nasdaq Global Select Market
Mar 03 2026
Globenewswire
Tonix Pharmaceuticals Successfully Uplists to Nasdaq Global Select Market
Mar 03 2026
Newsfilter
Tonix Pharmaceuticals Reports Positive Phase 3 Clinical Data for TONMYA
Jan 30 2026
NASDAQ.COM
TONMYA Shows Significant Pain Reduction in Fibromyalgia Treatment
Jan 30 2026
Newsfilter
Tonix Pharmaceuticals to Present at January 2026 Investor Conferences
Jan 06 2026
Globenewswire
Show More News
